<html><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><link type="text/css" href="css/redmond/jquery-ui.css" rel="stylesheet"><link type="text/css" href="css/mims.css" rel="stylesheet"><script type="text/javascript" src="scripts/jjQuery JavaScript Library v2.1.3.js"></script><script type="text/javascript" src="scripts/jquery-ui.min.js"></script><script type="text/javascript" src="scripts/drugalert.js"></script><style>
				div.drug-label {
						width: 90mm;
						height: 35mm;
				    border: 1pt solid;
				    border-radius: 5pt;
						padding: 5pt;
						margin-bottom: 5pt;
				}
				.drug-label h4 {
					font-size: 10pt;
					font-weight: bold;
					font-family: Arial;
					margin: 2pt;
				}
				.drug-label p {
					font-size: 8pt;
					font-weight: normal;
					font-family: Arial;
					margin: -1pt 2pt 2pt 2pt;
				}
				.cals-details p {
					margin-bottom: 0pt;
				}
				.cal-details li a {
				text-decoration: none;
				}

				.cal-details strong { margin-right: 2pt; }

				ol.allergy-list { padding-left: 1.33em; }
				ol.allergy-list > li { padding-top: 0.5em; }
				ol.allergy-list h4.subheading { margin-top: 0.2em; }
				</style><div id="tabs" class="tab-container"><ul><li><a href="#tab-interaction">Drug Interaction (1)</a></li><li><a href="#tab-lact">Lactation (1)</a></li></ul><div id="tab-interaction" class="acc_container"><div id="list_interactions"><div id="i_4_atorvastatin_calcium_fluconazole"><h3><a href="#"><table class="severity"><tbody><tr><td class="severity4"></td></tr></tbody></table>&nbsp;
	Lipitor FC tab 20 mg (atorvastatin calcium/Systemic) vs fluconazole 150mg Oral Tablet (fluconazole/Systemic)
						 [Use combination with extreme caution.]</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>atorvastatin calcium has its toxicity increased by fluconazole</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - 
These medications may interact resulting in the potential deterioration of the patient's condition. The patient should be monitored for the possible manifestations of the interaction. Medical intervention or a change in therapy may be required.
        </p><h4 class="subheading">Documentation Level</h4><p><em>Limited</em> - 
Few reports of this interaction exist. These few reports usually consist of limited case reports where clinically sound justification of the interaction is found.
        </p><div id="r_i_4_atorvastatin_calcium_fluconazole" style="display: block"><h4 class="subheading">Probable Mechanism</h4>Fluconazole may increase the toxicity of atorvastatin by inhibiting its CYP3A4-mediated metabolism. Isolated cases of rhabdomyolysis have been reported with the concomitant use of these agents. Monitor the patient for signs of atorvastatin adverse effects (e.g. unexplained muscle pain, tenderness or weakness). Use the lowest possible dose of atorvastatin during combined use.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with extreme caution.</li><li>Decrease drug dosage.</li><li>Monitor for signs of drug toxicity.</li></ol><h4 class="subheading">References</h4><ul><li>Anon. Atorvastatin interaction: Interaction with concomitant fluconazole leading to rhabdomyolysis in an elderly patient: case report. <i>Reactions Weekly</i>. 2007; 1179(1/Nov 24):9</li><li>Hsiao SH, Chang HJ, Hsieh TH et al. Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review. <i>J Clin Pharm Ther</i>. 2016; 41(5/Oct):575-8</li><li>Kahri J, Valkonen M, Bäcklund T et al. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. <i>Eur J Clin Pharmacol</i>. 2005; 60(12/Feb):905-7</li><li>Statins + Azoles. Stockleys Drug Interactions. MedicinesComplete. Preston CL (ed). RPS Publishing. London. UK.  Available from URL: <a href="http://www.medicinescomplete.com/mc">http://www.medicinescomplete.com/mc</a>. (Accessed on 21/02/2018)</li></ul></div></div></div></div></div><div id="tab-lact" class="acc_container"><div id="list_lact"><div id="la_lipitor_fc_tab_20_mg"><h3><a href="#">Lipitor FC tab 20 mg</a></h3><div><h4 class="subheading">Severity Level</h4><em>Contraindicated</em> - 
Human experience may or may not be available but these drugs can have severe toxicity to a nursing infant. The drug should not be given to a nursing mother. These drugs also include those that are indicated in conditions where lactation is a contraindication.<br><em>Description </em>-
				Statins are excreted in small amounts into milk of lactating animals. An isolated case observed the transfer of rosuvastatin into breast milk but does not discuss the safety of its use for infants. Breastfeeding is not recommended because of the potential for serious adverse effects in the infant (e.g. alteration in lipid metabolism).

<br><br><h4 class="subheading">References</h4><ul><li>Schutte AE, Symington EA, du Preez JL. Rosuvastatin is transferred into human breast milk: a case report. <i>Am J Med</i>. 2013; 126(9/Sep):e7-8</li><li>Abel T, Blázovics A, Kemény M et al. Hyperlipoproteinemia in pregnancy. <i>Orv Hetil</i>. 2011; 152(19/May 8):753-7</li><li>HMG-CoA Reductase Inhibitors General Statement. American Hospital Formulary Service Drug Information. MedicinesComplete. McEvoy GK (ed). RPS Publishing. London. UK.  Available from URL: <a href="http://www.medicinescomplete.com/mc">http://www.medicinescomplete.com/mc</a>. (Accessed on 11/11/2013)</li></ul></div></div></div></div></div></html>